Provided by Tiger Fintech (Singapore) Pte. Ltd.

ZYMEWORKS INC (US)

11.75
-0.1700-1.43%
Pre-market: 11.750.00000.00%05:27 EDT
Volume:1.10M
Turnover:12.99M
Market Cap:817.53M
PE:-7.26
High:12.08
Open:11.57
Low:11.54
Close:11.92
Loading ...

Stock Track | Zymeworks Soars Over 9% After Analyst Upgrade

Stock Track
·
07 Nov 2024

Stock Track | Zymeworks Inc Soars 8.9% Pre-Market After Analyst Upgrade

Stock Track
·
07 Nov 2024

Leerink Partners Upgrades Zymeworks to Outperform, $25 Price Target

MT Newswires Live
·
07 Nov 2024

Zymeworks Raised to Outperform From Market Perform by Leerink Partners

Dow Jones
·
07 Nov 2024

Zymeworks Inc : Leerink Partners Raises to Outperform From Market Perform

THOMSON REUTERS
·
07 Nov 2024

BRIEF-Zymeworks Doses First Patient In Phase 1 Trial Of ZW191 For Folate Receptor-⍺ Positive Advanced Tumors

Reuters
·
05 Nov 2024

Zymeworks says first patient dosed in Phase 1 trial of ZW191

TIPRANKS
·
05 Nov 2024

Zymeworks: Expects to Enroll Patients at Investigator Sites in North America, Europe, and Asia-Pacific Region

THOMSON REUTERS
·
05 Nov 2024

Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors

THOMSON REUTERS
·
05 Nov 2024

Stock Track | Zymeworks Soars on Upcoming Catalysts for Lead Drug Zanidatamab

Stock Track
·
04 Nov 2024

Zymeworks price target raised to $18 from $16 at Citi

TIPRANKS
·
04 Nov 2024

Zymeworks Third Quarter 2024 Earnings: Revenues Disappoint

Simply Wall St.
·
02 Nov 2024

Zymeworks’ Future Hinges on Developing Key Diagnostic Tests Amidst Regulatory Challenges

TIPRANKS
·
02 Nov 2024

Stock Track | Zymeworks Plummets Nearly 7% After Wells Fargo Downgrade and Mixed Earnings

Stock Track
·
01 Nov 2024

Zymeworks Shares Down 6.2% After Q3 Results

THOMSON REUTERS
·
01 Nov 2024

Zymeworks Price Target Maintained With a $12.00/Share by HC Wainwright & Co.

Dow Jones
·
01 Nov 2024

Zymeworks Cut to Equal-Weight From Overweight by Wells Fargo

Dow Jones
·
01 Nov 2024

Wells Fargo Downgrades Zymeworks to Equalweight From Overweight, PT is $12

MT Newswires Live
·
01 Nov 2024

Zymeworks Inc reports results for the quarter ended in January 1 - Earnings Summary

Reuters
·
01 Nov 2024

Zymeworks Q3 2024 GAAP EPS $(0.39) Beats $(0.47) Estimate, Sales $16.000M Miss $17.681M Estimate

Benzinga
·
01 Nov 2024